With 30 percent of the U.S. population still admitting they won’t or may not get the vaccine, physicians…
Blog
How risk stratification can protect lives and improve public health during COVID-19
COVID-19 vaccines are here, but the pandemic isn’t over. As vaccine distribution efforts continue, it becomes…
Frank Agullo, MD Receives “Top Plastic Surgeon of the Decade” and more in the Aesthetic Everything® Aesthetic and Cosmetic Medicine Awards 2021
Frank Agullo, MD Receives “Top Plastic Surgeon of the Decade”, “Top Aesthetic Doctor” and “Top Plastic…
WuXi Diagnostics Secures US$150 Million Series B Financing to Accelerate Market Penetration in Global Diagnostics Sector
WuXi Diagnostic Investment (Cayman) Limited (“WuXi Diagnostics”) announced that it has completed US$150 million in series B funding, joined…
Alternative meat startup Next Meats Co., Ltd and microalgae biotech company euglena Co., launch “NEXT Euglena Yakiniku EX” containing microalgae
Next Meats Co., LTD, the controlling shareholder of Next Meats Holdings, Inc. (“OTC: NXMH”) announced that they had…
Friday Health Plans Achieves 400% Membership Growth During Latest Open Enrollment Period for Health Insurance
Enrollment in Friday Health Plans, a health insurance carrier created for the individual and family market, grew…
WeHealth™ Digital Medicine and BioSerenity Initiate a New Phase to Accelerate Cardioskin™ Commercialization
WeHealth™ Digital Medicine, Servier Group’s e-health division, and BioSerenity, today announced that BioSerenity acquired the global…
The Valens Company Submits Site Evidence Package to Health Canada for Manufacturing Facility in Greater Toronto Area
The Valens Company” or “Valens“, a leading manufacturer of cannabis products, today announced that it has submitted…
Genetic Testing Billing Expert Michael F. Arrigo Releases Report Genetic Test Billing Practices, Ethics, Safety and Accuracy, Anti-Discrimination, Privacy
No World Borders, Inc. announced that genetic test billing expert Michael F. Arrigo published findings regarding insurance utilization,…
Gannex Announces Positive Clinical Results in Overweight and Obese Subjects for Its THR-β Agonist ASC41
Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672), fully dedicated to the R&D…